NEXENTIS TECHNOLOGIES INC. Payments to Acquire Other Investments
NEXENTIS TECHNOLOGIES INC. (NXTS) reported Payments to Acquire Other Investments of $199.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireOtherInvestments · last filed 2026-08-13
- NEXENTIS TECHNOLOGIES INC. payments to acquire other investments for the quarter ending 2026-06-30 was $83.00K.
- NEXENTIS TECHNOLOGIES INC. payments to acquire other investments for the quarter ending 2026-03-31 was $116.00K, a 79.43% decline year-over-year.
- NEXENTIS TECHNOLOGIES INC. payments to acquire other investments for the quarter ending 2025-06-30 was -$69.00K.
- NEXENTIS TECHNOLOGIES INC. payments to acquire other investments for the quarter ending 2025-03-31 was $564.00K.
- NEXENTIS TECHNOLOGIES INC. payments to acquire other investments for fiscal 2025 was $743.00K, a 197.20% increase from fiscal 2024.
- NEXENTIS TECHNOLOGIES INC. payments to acquire other investments for fiscal 2024 was $250.00K, a 83.79% decline from fiscal 2023.
- NEXENTIS TECHNOLOGIES INC. payments to acquire other investments for fiscal 2023 was $1.54M.
USD
| Period end | Payments to Acquire Other Investments 1 month | Payments to Acquire Other Investments 3 month | Payments to Acquire Other Investments 6 month | Payments to Acquire Other Investments 9 month | Payments to Acquire Other Investments 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $83.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $199.00K 10-Q · filed 2026-08-13 | |||
| 2026-03-31 | $116.00K 10-Q · filed 2026-05-14 | ||||
| 2025-12-31 | $743.00K 10-K · filed 2026-03-31 | ||||
| 2025-06-30 | $436.00K 10-Q · filed 2025-11-13 | -$69.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $495.00K 10-Q · filed 2026-08-13 | $542.00K derived: sum of 3 quarters · filed 2026-08-13 | $583.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $564.00K 10-Q · filed 2026-05-14 | $611.00K derived: sum of 2 quarters · filed 2026-05-14 | $652.00K derived: sum of 3 quarters · filed 2026-05-14 | ||
| 2025-01-31 | $436.00K 10-Q · filed 2025-11-13 | ||||
| 2024-12-31 | $47.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $88.00K derived: sum of 2 quarters · filed 2026-03-31 | $250.00K 10-K · filed 2026-03-31 | ||
| 2024-09-30 | $41.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $203.00K 10-Q · filed 2025-11-13 | |||
| 2024-06-30 | $162.00K 10-Q · filed 2025-08-14 | ||||
| 2023-12-31 | $1.54M 10-K · filed 2025-03-31 |
EUR
| Period end | Payments to Acquire Other Investments 1 month |
|---|---|
| 2025-06-30 | 424.00K EUR 10-Q · filed 2025-11-13 |
| 2025-01-31 | 424.00K EUR 10-Q · filed 2025-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |